Möginger, U., Resemann, A., Martin, C. E., Parameswarappa, S., Govindan, S., Wamhoff, E.-C., Broecker, F., Suckau, D., Pereira, C. L., Chakkumkal, A., Seeberger, P. H., & Kolarich, D. (2016). Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites. Scientific Reports, 6:. doi:10.1038/srep20488.